Aura Biosciences（AURA.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

股东类型

机构投资者67.33%
风投/私募19.87%
对冲基金6.95%
公众及其他4.65%
个人与内部人士1.20%

主要股东

主要股东最新
股东
TCG Crossover Management, LLC	9.19%	953.33 万	--	+953.33 万	2026/06/30
Montanova Capital, LLC	6.95%	720.62 万	0.13%	+283.33 万	2026/06/30
Frazier Life Sciences Management, LP	5.62%	582.50 万	2.33%	+72.50 万	2026/06/30
Forbion Capital Partners B.V.	5.06%	524.88 万	1.14%	+119.51 万	2026/09/25
Long Focus Capital Management LLC	4.94%	511.96 万	2.26%	+50.00 万	2026/06/30
Vanguard Capital Management, LLC	4.57%	473.75 万	0.45%	+209.66 万	2026/06/30
BlackRock, Inc.	4.54%	470.77 万	1.05%	+112.10 万	2026/06/30
Adage Capital Management, L.P.	4.47%	464.00 万	3.13%	-24.11 万	2026/06/30
Caligan Partners, LP	4.14%	429.82 万	3.79%	+406.84 万	2026/06/30
OrbiMed Advisors LLC	3.21%	333.33 万	--	+333.33 万	2026/06/30
Medicxi Ventures (UK) LLP	2.93%	303.99 万	1.81%	+0	2026/06/30
Nantahala Capital Management, LLC	2.85%	295.10 万	0.46%	+83.33 万	2026/06/30
RA Capital Management, L.P.	2.41%	250.00 万	--	+250.00 万	2026/06/30
Janus Henderson Group Ltd.	2.41%	250.00 万	--	+250.00 万	2026/06/30
Balyasny Asset Management L.P.	2.27%	235.46 万	1.40%	+179.70 万	2026/06/30
Franklin Templeton Inc.	2.00%	207.22 万	1.23%	+0	2026/06/30
Advent Life Sciences LLP	1.95%	202.39 万	1.20%	+0	2026/02/13
Geode Capital Management, LLC	1.69%	175.47 万	0.35%	+44.39 万	2026/06/30
Redmile Group, LLC	1.61%	166.67 万	--	+166.67 万	2026/06/30
EcoR1 Capital, LLC	1.61%	166.67 万	--	+166.67 万	2026/06/30